IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Merck KGaA affirms commitment to China, will break ground on pharma unit

5:14 AM MDT | July 23, 2014 | Natasha Alperowicz

Merck KGaA at today’s press conference at Shanghai affirmed its commitment to China. Merck will in August hold a groundbreaking ceremony for a previously announced €80 million ($107.8 million) pharmaceuticals plant at Nantong, which, from 2017, will be the group’s second-largest pharmaceuticals manufacturing facility globally. It will focus on bulk production and packaging of Glucophage, Concor and Euthyrox, Merck’s brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders.   “China is of strategic...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa